Kelyniam Global Announces Q2 2026 Financial Results
Kelyniam Global to Present at Planet MicroCap Las Vegas 2026 - From Single Product to Regenerative Medicine Leader
Kelyniam Global Announces Strong Q1 2026 Financial Results
Kelyniam Global Reports 2025 Financial Results
Kelyniam Global Announces Q3 2025 Financial Results
Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products
Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion™ BCP-PEEK Implant
Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
